Evidence map›Paper›PMID 38049560›Full record

ArticleNature human behaviour2024

COVID-19 vaccination coverage for half a million non-EU migrants and refugees in England.

Rachel Burns, Sacha Wyke, Max T Eyre, Yamina Boukari, Tina B Sørensen, Camille Tsang, Colin N J Campbell, Sarah Beale, Dominik Zenner, Sally Hargreaves and 3 more

Erratum issuedOpen access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature human behaviour, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Rachel BurnsCentre for Public Health Data Science, Institute of Health Informatics, University College London, London, UK. r.burns@ucl.ac.uk.ORCID 0000-0002-9559-2867
Sacha WykeDepartment of Health and Social Care, Office for Health Improvement and Disparities, London, UK.
Max T EyreDepartment of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0001-9847-8632
Yamina BoukariCentre for Public Health Data Science, Institute of Health Informatics, University College London, London, UK.ORCID 0000-0002-9171-6922
Tina B SørensenImmunisation and Vaccine Preventable Diseases, UK Health Security Agency, London, UK.ORCID 0000-0003-1517-6159
Camille TsangImmunisation and Vaccine Preventable Diseases, UK Health Security Agency, London, UK.
Colin N J CampbellImmunisation and Vaccine Preventable Diseases, UK Health Security Agency, London, UK.
Sarah BealeCentre for Public Health Data Science, Institute of Health Informatics, University College London, London, UK.
Dominik ZennerGlobal Public Health Unit, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID 0000-0002-9200-6180
Sally HargreavesInstitute for Infection and Immunity, St George's University of London, Cranmer Terrace London, London, UK.
Ines Campos-MatosDepartment of Health and Social Care, Office for Health Improvement and Disparities, London, UK.ORCID 0000-0002-6480-4310
Katie HarronUCL Great Ormond Street, Institute of Child Health, University College London, London, UK.ORCID 0000-0002-3418-2856
Robert W AldridgeCentre for Public Health Data Science, Institute of Health Informatics, University College London, London, UK.
University College London · GBUK Health Security Agency · GBDepartment of Health and Social Care · GBHealth Data Research UK · GBLondon School of Hygiene & Tropical Medicine · GBQueen Mary University of London · GBSt George's, University of London · GB

Funding

Medical Research Council MR/V028375/1Wellcome TrustWellcome Trust 206602
6 · The paper itself

Abstract

Despite evidence suggesting that some migrants are at risk of under-immunization and have experienced severe health inequities during the pandemic, data are limited on migrants' COVID-19 vaccine coverage globally. Here we linked data from non-European Union migrants and resettled refugees to the national COVID-19 vaccination dataset in England. We estimated patterns in second and third dose delays and overdue doses between 12 December 2020 and 20 April 2022 by age, visa type and ethnicity. Of the 465,470 linked records, 91.8% (427,073/465,470) of migrants received a second dose and 51.3% (238,721/465,470) received a third. Refugees had the highest risk of delayed second (adjusted odds ratio 1.66; 95% confidence interval 1.55-1.79) and third dose (1.55; 1.43-1.69). Black migrants were twice as likely to have a second dose delayed (2.37; 2.23-2.54) than white migrants, but this trend reversed for the third dose. Older migrants (>65 years) were four times less likely to have received their second or third dose compared with the general population in England aged >65 or older. Policymakers, researchers and practitioners should work to understand and address personal and structural barriers to vaccination for diverse migrant populations.

Indexed as

COVID-19RefugeesTransients and MigrantsCOVID-19 VaccinesHumansVaccinationVaccination CoverageCOVID-19 Vaccines

Identifiers

PMID38049560
PMCPMC10896718
OpenAlexW4389306497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.